The 10th Breast, Gynecological and Immuno-oncology International Cancer Conference (BGIICC), 2018 Scientific Program is designed to give a good platform for the exchange of experience on cancers and to outline the actual status of the problems relating to the Breast and Gynecological cancers, with discussion of the prospects in the context of the most recent international trends and initiatives for the treatment. SITC Speakers at the Conference:
Session AgendaJanuary 18, 2018 The 2nd Wave Immunotherapy Tsunami Session
2:00 – 2:20 p.m.
1st BGICS-SITC Clinical Practice Recommendation in Immune-Oncology Hesham El Ghazaly, MD – Alfa Cure Center
2:20 – 2:35 p.m.
Biomarkers Beyond PDL-1 for Immune-Therapy: TILs, TMB and others: The Way for Patients’ Selection Christian Rolfo, MD, PhD, MDAh – University of Antwerp
2:35 – 2:50 p.m.
Solving the Hard Question in IO: Sequencing Versus Combination, Timing, and Duration Neal E. Ready, MD, PhD – Duke University Medical Center
2:50 – 3:05 p.m.
Potential Role of Immune-Therapy in the Pre-Metastatic Setting Leisha Emens, MD, PhD – Johns Hopkins University
3:05 – 3:25 p.m.
Combination Immune-Therapy: The Rationale and Outcomes Moshen Mokhtar, MD – Cairo University, Center of Radiation Oncology and Nuclear Medicine
3:25 – 3:45 p.m.
Immunotherapy in Lung Cancer: The Full Story Neal E. Ready, MD, PhD – Duke University Medical Center
3:45 – 4:05 p.m.
Driving Mutations in Lung Cancer: Hitting the New and Old Targets and Immunotherapy RoleChristian Rolfo, MD, PhD, MDAh – University of Antwerp
Tel: +1 414 271 2456 | Fax: +1 414 276 3349 | Email: email@example.com